Semaglutide - Pharmacodynamic and Pharmacokinetic Characteristics of a New Long-Acting GLP-1-Receptor Agonist

Nauck, MA; Gallwitz, B; Seufert, J

Nauck, MA (reprint author), Ruhr Univ Bochum, St Josef Hosp, Diabetol, Gudrunstr 56, D-44791 Bochum, Germany.

DIABETOLOGIE UND STOFFWECHSEL, 2017; 12 (2): 135

Abstract

Semaglutide is a GLP-1 agonist, which shows a 94 % amino acid homology to human GLP-1. Due to molecular modifications, Semaglutide binds after s.c. in......

Full Text Link